[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@HothInc](/creator/twitter/HothInc) "Hoth Therapeutics has expanded its AI initiative through a new NVIDIA AI Enterprise subscription license to accelerate data-driven drug development preclinical modeling and predictive analytics. Read more: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1975946033403216162) [@HothInc](/creator/x/HothInc) 2025-10-08T15:27Z XXX followers, XXX engagements "Were proud to share that preclinical results highlighting the potent antitumor effects of HT-KIT our promising cancer drug are featured by @RareDisease_Adv. Read more: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1978445788549099764) [@HothInc](/creator/x/HothInc) 2025-10-15T13:00Z XXX followers, XX engagements "Our HT-001 drug is being developed to address skin side effects from cancer treatments strengthening Hoths position in oncology support care. Continue reading: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1978476014243102766) [@HothInc](/creator/x/HothInc) 2025-10-15T15:00Z XXX followers, XX engagements "The new patent applications demonstrate Hoth's commitment to unlocking the full therapeutic potential of HT-001 across multiple high-value indications. For more info visit: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1978808243905241259) [@HothInc](/creator/x/HothInc) 2025-10-16T13:00Z XXX followers, XX engagements "We believe biotech must go beyond drug development and marketing. Were committed to delivering therapies that truly address the needs of patients and their families. 🩺 Read: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1979170547998072949) [@HothInc](/creator/x/HothInc) 2025-10-17T13:00Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@HothInc
"Hoth Therapeutics has expanded its AI initiative through a new NVIDIA AI Enterprise subscription license to accelerate data-driven drug development preclinical modeling and predictive analytics. Read more: NASDAQ: $HOTH"
X Link @HothInc 2025-10-08T15:27Z XXX followers, XXX engagements
"Were proud to share that preclinical results highlighting the potent antitumor effects of HT-KIT our promising cancer drug are featured by @RareDisease_Adv. Read more: NASDAQ: $HOTH"
X Link @HothInc 2025-10-15T13:00Z XXX followers, XX engagements
"Our HT-001 drug is being developed to address skin side effects from cancer treatments strengthening Hoths position in oncology support care. Continue reading: NASDAQ: $HOTH"
X Link @HothInc 2025-10-15T15:00Z XXX followers, XX engagements
"The new patent applications demonstrate Hoth's commitment to unlocking the full therapeutic potential of HT-001 across multiple high-value indications. For more info visit: NASDAQ: $HOTH"
X Link @HothInc 2025-10-16T13:00Z XXX followers, XX engagements
"We believe biotech must go beyond drug development and marketing. Were committed to delivering therapies that truly address the needs of patients and their families. 🩺 Read: NASDAQ: $HOTH"
X Link @HothInc 2025-10-17T13:00Z XXX followers, XX engagements
/creator/twitter::1050398617280933888/posts